IRTC IRhythm Technologies Inc.

iRhythm Technologies to Report Third Quarter 2022 Financial Results on November 1, 2022

iRhythm Technologies to Report Third Quarter 2022 Financial Results on November 1, 2022

SAN FRANCISCO, Oct. 20, 2022 (GLOBE NEWSWIRE) -- (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced that it will release financial results for the third quarter 2022 after the close of trading on Tuesday, November 1, 2022. The company’s management team will host a corresponding conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET.

Investors interested in listening to the conference call may do so by accessing the live and archived webcast of the event available on the investors section of the Company’s website at .

About iRhythm Technologies, Inc.

iRhythm is a leading digital health care company that creates trusted solutions that detect, predict, and prevent disease. Combining wearable biosensors and cloud-based data analytics with powerful proprietary algorithms, iRhythm distills data from millions of heartbeats into clinically actionable information. Through a relentless focus on patient care, iRhythm’s vision is to deliver better data, better insights, and better health for all.

Investor Relations Contact

Stephanie Zhadkevich

(919) 452-5430

iRhythm Media Contact

Morgan Mathis

(310) 528-6306



EN
20/10/2022

Underlying

IRTCIRhythm Technologies Inc.

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on IRhythm Technologies Inc.

Free Trial
IRTC IRhythm Technol...

Irhythm Technologies Inc: 2 directors

A director at Irhythm Technologies Inc sold 2,555 shares at 158.970USD and the significance rating of the trade was 53/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two year...

IRTC IRHYTHM TECHNOLOGIES INC.
08/07/25 August 7, 2025 1 EN
 PRESS RELEASE
Free
IRTC IRhythm Technol...

iRhythm and Lucem Health Partner to Introduce Predictive AI Solution f...

iRhythm and Lucem Health Partner to Introduce Predictive AI Solution for Early Detection of Arrhythmias in Patient Populations with Comorbid Conditions Partnership aims to utilize predictive AI to help identify arrhythmias earlier in patient populations with an elevated risk for arrhythmias to enable timely care for millions who remain undiagnosedCommercial offering from this collaboration designed to support scalable population health and value-based care strategies SAN FRANCISCO, July 31, 2025 (GLOBE NEWSWIRE) -- (NASDAQ:IRTC), a digital health leader focused on creating trusted solut...

July 31, 2025 1 EN
 PRESS RELEASE
Free
IRTC IRhythm Technol...

iRhythm Technologies Announces Second Quarter 2025 Financial Results

iRhythm Technologies Announces Second Quarter 2025 Financial Results SAN FRANCISCO, July 31, 2025 (GLOBE NEWSWIRE) --  (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today reported financial results for the three months ended June 30, 2025. Second Quarter 2025 Financial Highlights Revenue of $186.7 million, a 26.1% increase compared to second quarter 2024Gross margin of 71.2%, a 130-basis point increase compared to second quarter 2024Unrestricted cash, cash equivalents, and marketable securit...

July 31, 2025 1 EN
 PRESS RELEASE
Free
IRTC IRhythm Technol...

iRhythm Technologies to Report Second Quarter 2025 Financial Results o...

iRhythm Technologies to Report Second Quarter 2025 Financial Results on July 31, 2025 SAN FRANCISCO, July 17, 2025 (GLOBE NEWSWIRE) -- (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced that it will release financial results for the second quarter 2025 after the close of trading on Thursday, July 31, 2025. The company’s management team will host a corresponding conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET. Interested parties may access a live and archived webcast of the confere...

July 17, 2025 1 EN
 PRESS RELEASE
Free
IRTC IRhythm Technol...

iRhythm Technologies Announces Board Member Retirements and New Direct...

iRhythm Technologies Announces Board Member Retirements and New Director Appointments SAN FRANCISCO, July 07, 2025 (GLOBE NEWSWIRE) -- (NASDAQ:IRTC) , a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today announced the retirement of two long-serving board members, Mark Rubash and Ralph Snyderman, M.D., effective July 7, 2025. Concurrently, Karen McGinnis and Kevin O’Boyle have accepted appointments to the board of directors. Mark Rubash has served on the board since 2016, prior to the company’s initial public offerin...

July 7, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch